Literature DB >> 25311922

Methods for gene transfer to the central nervous system.

Boris Kantor1, Rachel M Bailey2, Keon Wimberly2, Sahana N Kalburgi2, Steven J Gray3.   

Abstract

Gene transfer is an increasingly utilized approach for research and clinical applications involving the central nervous system (CNS). Vectors for gene transfer can be as simple as an unmodified plasmid, but more commonly involve complex modifications to viruses to make them suitable gene delivery vehicles. This chapter will explain how tools for CNS gene transfer have been derived from naturally occurring viruses. The current capabilities of plasmid, retroviral, adeno-associated virus, adenovirus, and herpes simplex virus vectors for CNS gene delivery will be described. These include both focal and global CNS gene transfer strategies, with short- or long-term gene expression. As is described in this chapter, an important aspect of any vector is the cis-acting regulatory elements incorporated into the vector genome that control when, where, and how the transgene is expressed.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AAV; Adenovirus; CNS; Gene therapy; Lentivirus; Plasmid; Promoter; Vector

Mesh:

Year:  2014        PMID: 25311922      PMCID: PMC4519829          DOI: 10.1016/B978-0-12-800149-3.00003-2

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  333 in total

1.  Herpes simplex virus mediated gene transfer to primate ocular tissues.

Authors:  X Liu; C R Brandt; B T Gabelt; P J Bryar; M E Smith; P L Kaufman
Journal:  Exp Eye Res       Date:  1999-10       Impact factor: 3.467

2.  Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain.

Authors:  Cassia N Cearley; John H Wolfe
Journal:  Mol Ther       Date:  2006-01-18       Impact factor: 11.454

3.  High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors.

Authors:  Hilda Petrs-Silva; Astra Dinculescu; Qiuhong Li; Seok-Hong Min; Vince Chiodo; Ji-Jing Pang; Li Zhong; Sergei Zolotukhin; Arun Srivastava; Alfred S Lewin; William W Hauswirth
Journal:  Mol Ther       Date:  2008-12-16       Impact factor: 11.454

Review 4.  TAT-based drug delivery system--new directions in protein delivery for new hopes?

Authors:  Matan Rapoport; Haya Lorberboum-Galski
Journal:  Expert Opin Drug Deliv       Date:  2009-05       Impact factor: 6.648

5.  RNA-dependent DNA polymerase in virions of Rous sarcoma virus.

Authors:  H M Temin; S Mizutani
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

6.  Sequence requirements for integration of Moloney murine leukemia virus DNA in vitro.

Authors:  F D Bushman; R Craigie
Journal:  J Virol       Date:  1990-11       Impact factor: 5.103

7.  BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia.

Authors:  F J Antonawich; H J Federoff; J N Davis
Journal:  Exp Neurol       Date:  1999-03       Impact factor: 5.330

Review 8.  HIV-1 envelope glycoprotein structure.

Authors:  Alan Merk; Sriram Subramaniam
Journal:  Curr Opin Struct Biol       Date:  2013-04-18       Impact factor: 6.809

9.  VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model.

Authors:  Mimoun Azzouz; G Scott Ralph; Erik Storkebaum; Lucy E Walmsley; Kyriacos A Mitrophanous; Susan M Kingsman; Peter Carmeliet; Nicholas D Mazarakis
Journal:  Nature       Date:  2004-05-27       Impact factor: 49.962

10.  A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.

Authors:  M I Bukrinsky; S Haggerty; M P Dempsey; N Sharova; A Adzhubel; L Spitz; P Lewis; D Goldfarb; M Emerman; M Stevenson
Journal:  Nature       Date:  1993-10-14       Impact factor: 69.504

View more
  35 in total

1.  Downregulation of SNCA Expression by Targeted Editing of DNA Methylation: A Potential Strategy for Precision Therapy in PD.

Authors:  Boris Kantor; Lidia Tagliafierro; Jeffrey Gu; Madison E Zamora; Ekaterina Ilich; Carole Grenier; Zhiqing Y Huang; Susan Murphy; Ornit Chiba-Falek
Journal:  Mol Ther       Date:  2018-08-29       Impact factor: 11.454

2.  Timing of Gene Therapy Interventions: The Earlier, the Better.

Authors:  Steven J Gray
Journal:  Mol Ther       Date:  2016-06       Impact factor: 11.454

Review 3.  Selective Manipulation of Neural Circuits.

Authors:  Hong Geun Park; Jason B Carmel
Journal:  Neurotherapeutics       Date:  2016-04       Impact factor: 7.620

Review 4.  Strategies for delivering therapeutics across the blood-brain barrier.

Authors:  Georg C Terstappen; Axel H Meyer; Robert D Bell; Wandong Zhang
Journal:  Nat Rev Drug Discov       Date:  2021-03-01       Impact factor: 84.694

5.  A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells.

Authors:  Sriram Vijayraghavan; Boris Kantor
Journal:  J Vis Exp       Date:  2017-12-12       Impact factor: 1.355

Review 6.  Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.

Authors:  Jana Miniarikova; Melvin M Evers; Pavlina Konstantinova
Journal:  Mol Ther       Date:  2018-02-08       Impact factor: 11.454

7.  Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models.

Authors:  Lidia Tagliafierro; Ekaterina Ilich; Malik Moncalvo; Jeffrey Gu; Ahila Sriskanda; Carole Grenier; Susan K Murphy; Ornit Chiba-Falek; Boris Kantor
Journal:  J Vis Exp       Date:  2019-03-29       Impact factor: 1.355

8.  Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).

Authors:  Megan E Bosch; Amy Aldrich; Rachel Fallet; Jessica Odvody; Maria Burkovetskaya; Kaitlyn Schuberth; Julie A Fitzgerald; Kevin D Foust; Tammy Kielian
Journal:  J Neurosci       Date:  2016-09-14       Impact factor: 6.167

9.  Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism.

Authors:  S K Powell; N Khan; C L Parker; R J Samulski; G Matsushima; S J Gray; T J McCown
Journal:  Gene Ther       Date:  2016-09-15       Impact factor: 5.250

Review 10.  Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.

Authors:  Toshiharu Nagatsu; Ikuko Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2016-08-04       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.